Head-to-head for moms
CoreAge Rx vs NuuVim
CoreAge Rx and NuuVim both offer GLP-1 telehealth to mothers, but they make different trade-offs on family-budget value, clinical oversight, price and access. Here they are side-by-side on the Editors' Rating — our six-factor rubric for mothers.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Mothers who want to know the real monthly cost before the free trial talks them into it — one flat price on semaglutide or tirzepatide, everywhere in the country, with no lock-in.
Visit CoreAge RxNuuVim
Ranked #61 · Grade C
Best for: A mother who wants a genuinely needle-free option at no price penalty and will confirm the refill rate and her own state directly before committing past the first month.
Visit NuuVimThe verdict
CoreAge Rx edges out NuuVim on the Editors' Rating, 94 to 64 (A vs C). Mothers who want to know the real monthly cost before the free trial talks them into it — one flat price on semaglutide or tirzepatide, everywhere in the country, with no lock-in.
NuuVim is still a genuine option — a rare same-price injectable/oral parity — $79/mo semaglutide, $133/mo tirzepatide either way — but that's a standing new-patient tier with an unpublished refill rate, its brand Ozempic and Zepbound run well above manufacturer self-pay pricing, and its own live site doesn't confirm the all-50-states claim found elsewhere. Weigh the six factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | NuuVim |
|---|---|---|
| Editors' Rating | 94/100 · A | 64/100 · C |
| Overall rank | #1 | #61 |
| Semaglutide | $99/mo | $79/mo |
| Tirzepatide | $149/mo | $133/mo |
| Coverage | All 50 states | Not disclosed by NuuVim's own live site — not verified by observation |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat all-in price that doesn't step up after month one — the number you sign for is the number at the full dose
- Both compounded semaglutide and tirzepatide on a single account, so a molecule switch never resets the budget
- Licensed in all 50 states — care survives a move, a deployment, or a summer at the grandparents'
The caveats
- Not the rock-bottom sticker price — a bare teaser tier elsewhere can look cheaper for exactly one month
- Compounded only; no FDA-approved brand Wegovy or Zepbound if that is what you and your clinician want
- A general metabolic program, not a dedicated women's or maternal-health clinic
NuuVim
Ranked #61 · Grade C
What we like
- Injectable and oral priced identically on both molecules — a real, uncommon needle-free option at no markup
- LegitScript-certified and HIPAA-compliant, with a clear, verbatim FDA compounding disclaimer
- One of the lowest new-patient headline prices on this roster
The caveats
- The $79/$133 figures are a new-patient tier; the follow-on refill price isn't published anywhere on-site
- Brand Ozempic ($1,498/mo) and Zepbound ($1,892/mo) both run far above the manufacturers' own self-pay programs
- A third-party directory's 'all 50 states + DC' claim could not be confirmed on NuuVim's own live site
We may earn a referral fee if you sign up through a link on this page, at no extra cost to you — and it has no bearing on which provider scores higher. Pricing, states and verification reflect each provider's public disclosures at last review; the Editors' Rating is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and NuuVim against other providers we review for mothers.
Or browse the full comparison hub.